PC
KURA icon

Polar Capital’s Kura Oncology KURA Stock Holding History

Polar Capital’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$15.3M Buy
+500,000
New +$11M 0.11% 154

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Polar Capital's KURA Position: Q3 2020 in Review

Polar Capital opened a new position in Kura Oncology (KURA) in Q3 2020: 500,000 shares worth $15.3M. The stake represents 0.11% of the portfolio and ranks #154 among its holdings.

162 funds tracked by Wall St. Rank hold KURA as of Q3 2020.

  • Polar Capital held 500,000 shares of Kura Oncology worth $15.3M as of Q3 2020.
  • Kura Oncology was a new Polar Capital position in Q3 2020.
  • Kura Oncology made up 0.11% of Polar Capital's portfolio in Q3 2020, its #154 holding.
  • 162 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2020.

Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.